Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and ...

“We still have a few weeks to have this discussion and negotiation,” French Trade Minister Laurent Saint-Martin said in Paris ...